您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

邱泰然醫師

肺癌、大腸直腸癌、膽胰癌
  • 國語,英語,閩南語
  • 副教授
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 高雄長庚醫院 血液腫瘤科主治醫師
  • 學歷
    • 高雄醫學大學醫學系畢業
  • 經歷
    • 高雄榮民總醫院 實習醫師
    • 高雄醫學大學附設醫院 內科部住院醫師
    • 高雄長庚醫院 內科部住院醫師
    • 高雄長庚醫院 血液腫瘤科住院醫師
  • 學會與認證
    • 中華民國癌症醫學會
    • 台灣內科醫學會
  • 論文及期刊發表
    • Tai-Jan Chiu. Notch3 expression affects aggressive phenotypes of pancreatic ductal adenocarcinoma.

    • Comparison of Fungal and Non-Fungal Rhinosinusitis by Culture-Based Analysis. J Pers Med. 2023 Sep 11;13(9):1368. doi: 10.3390/jpm13091368 (SCI;IF=3.4; Health care 41/106)

      Cha CH, Chen WC, Wang YM, Wu SC, Chiu TJ, Wu CN, Wee Y, Wang CS, Yang YH, Luo SD.
    • Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma. Cancer Cell Int. 2023 Sep 24;23(1):212. doi: 10.1186/s12935-023- 03060-z (SCI;IF=5.8; Oncology 60/242)

      Chiu TJ, Chen CH, Chen YJ, Wee Y, Wang CS, Luo SD.
    • Clinical Value of Endoscopic Esophageal Screening in Head and Neck Squamous Cell Carcinoma Patients. Otolaryngol Head Neck Surg. 2023 Sep 20. doi: 10.1002/ohn.51 (SCI;IF=3.4; Otorhinolaryngology 5/4311)

      Chen WC, Wu CN, Wang YM, Chiu TJ, Wu SC, Yang YH, Luo SD.
    • Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells. Am J Cancer Res. 2023 Apr 15;13(4):1209-1239. eCollection 2023 (SCI;IF=5.3; Oncology 70/242)

      Nie L, Wang YN, Hsu JM, Hou J, Chu YY, Chan LC, Huo L, Wei Y, Deng R, Tang J, Hsu YH, Ko HW, Lim SO, Huang K, Chen MK, Chiu TJ, Cheng CC, Fang YF, Li CW, Goverdhan A, Wu HJ, Lee CC, Wang WL, Hsu J, Chiao P, Wang SC, Hung MC.
    • Safety and effectiveness of transdermal buprenorphine in cancer pain: An observational study in Taiwan (SOOTHE). Asia Pac J Clin Oncol. 2023 Apr;19(2):e45-e53. doi: 10.1111/ajco.13772 (SCI;IF=1.9; Oncology 214/242)

      Huang TL, Huang YM, Hou MM, Lu CH, Chao TY, Chiu TJ, Chang YS, Lin SH, Lin CH, Chen YH, Wang CH, Chen JS, Shen WC.
    • Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers (Basel). 2023 Feb 5;15(4):1008. doi: 10.3390/cancers15041008

      Su YY, Chiang NJ, Yang YH, Yen CJ, Bai LY, Chiu CF, Chuang SC, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chan DC, Peng CM, Chiu SC, Li CP, Shan YS, Chen LT.
    • The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma. Am J Cancer Res. 2022 Nov 15;12(11):5062-5073. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)

      Chiang NJ, Shan YS, Li CP, Yang SH, Su YY, Chiu SC, Bai LY, Chuang SC, Chan DC, Yen CJ, Peng CM, Chiu TJ, Chen YY, Chen JS, Chou WC.
    • Predictive value of albumin combined with neutrophil-to- lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. Am J Cancer Res. 2022 Sep 15;12(9):4267-4278. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)

      Chen YY, Hsueh SW, Yang SH, Chiu SC, Chiang NJ, Chiu TJ, Li CP, Bai LY, Chiu CF, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen JS, Chou WC.
    • Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study. Front Oncol. 2022 Aug 29;12:952616. doi: 10.3389/fonc.2022.952616. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)

      Chao CY, Luo SD, Chen WC, Wu SC, Chiu TJ, Wang YM, Yang YH, Fang FM, Li SH, Li CY, Wu CN.
    • Clinical Characteristics and Predictive Outcomes of Recurrent Nasopharyngeal Carcinoma-A Lingering Pitfall of the Long Latency. Cancers (Basel). 2022 Aug 4;14(15):3795. doi: 10.3390/cancers14153795. (SCI;IF=5.2; Oncology 71/242)

      Chen YH, Luo SD, Wu SC, Wu CN, Chiu TJ, Wang YM, Yang YH, Chen WC.
    • Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study. Front Oncol. 2022 Jun 22;12:800842. doi: 10.3389/fonc.2022.800842. eCollection 2022 (SCI;IF=4.7; Oncology 85/242)

      Su YY, Chiang NJ, Li CP, Yen CJ, Yang SH, Chou WC, Chen JS, Chiu TJ, Chen YY, Chuang SC, Bai LY, Chiu CF, Peng CM, Chan DC, Chiu SC, Yang YH, Shan YS, Chen LT.
    • Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. J Exp Clin Cancer Res. 2022 Jul 1;41(1):215. doi: 10.1186/s13046-022-02415-0. (SCI;IF=11.3; Oncology 25/242)

      Luo SD, Tsai HT, Hwang CF, Chiu TJ, Li SH, Hsu YL, Hsiao CC, Chen CH.
    • Leptin Silencing Attenuates Lipid Accumulation through Sterol Regulatory Element-Binding Protein 1 Inhibition in Nasopharyngeal Carcinoma. Int J Mol Sci. 2022 May 20;23(10):5700. doi: 10.3390/ijms23105700. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)

      Luo SD, Tsai HT, Chiu TJ, Li SH, Hsu YL, Su LJ, Tsai MH, Lee CY, Hsiao CC, Chen CH.
    • The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan. Am J Cancer Res. 2022 Apr 15;12(4):1884-1898. eCollection 2022 (SCI;IF=5.3; Oncology 70/242)

      Yang SH, Chiang NJ, Chiu SC, Chou WC, Bai LY, Li CP, Su YY, Chiu TJ, Chuang SC, Peng CM, Chan DC, Chen JS, Yen CJ, Chen YY, Chiu CF, Chen LT, Shan YS.
    • Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin. J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):670-681. doi: 10.1002/jhbp.1128. Epub 2022 Mar 2. (SCI;IF=3; Surgery 58/212)

      Chiu TJ, Yang SH, Chiu SC, Hsueh SW, Chiang NJ, Li CP, Bai LY, Cheng FM, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Su YY, Chen YY, Chen JS, Chou WC.
    • Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers. Cancers (Basel). 2022 Jan 29;14(3):703. doi: 10.3390/cancers14030703 (SCI;IF=5.2; Oncology 71/242)

      Lee CL, Chen WS, Wee Y, Wang CS, Chen WC, Chiu TJ, Wang YM, Wu CN, Yang YH, Luo SD, Wu SC.
    • Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients`experience within a population-based study. Ther Adv Med Oncol. 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. eCollection 2021 (SCI;IF=4.9; Oncology 78/242)

      Chiu TJ, Su YY, Yang SH, Li CP, Bai LY, Chiang NJ, Chuang SC, Shan YS, Chan DC, Chen LT, Yen CJ, Peng CM, Chen YY, Chen JS, Chou WC.
    • Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study. PLoS One 2021 Dec 2;16(12):e0260772. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)

      Wu CN, Wu SC, Chen WC, Yang YH, Chin JC, Chien CY, Fang FM, Li SH, Luo SD, Chiu TJ*.
    • Nanoliposomal Irinotecan Pre-Emptive Dose Reduction in Patients with Pancreatic Ductal Adenocarcinoma: 667 Patients’ Experience within a Population-Based Study. Therapeutic Advances in Medical Oncology . 2021 Nov 20;13:17588359211058255. doi: 10.1177/17588359211058255. (SCI;IF=4.9; Oncology 78/242)

      Tai-Jan Chiu, Yung-Yeh Su, Shih-Hung Yang, Chung-Pin Li, Li-Yuan Bai6, Nai-Jung Chiang,Shih-Chang Chuang, Yan-Shen Shan, De-Chuan Chan, Li- Tzong Chen, Chia-Jui Yen, Cheng-Ming Peng, Yen-Yang Chen, Jen-Shi Chen, Wen-Chi Chou*.
    • Downregulation of Notch3 links TIMP3 inhibition to suppress aggressive phenotypes of pancreatic ductal adenocarcinoma, American Journal of Cancer Research (SCI;IF=5.3; Oncology 70/242)

      Tai-Jan Chiu, Yi-Ju Chen, Jui Lan, Yen-Yang Chen, Yueh-Chiu Chen, Shiao-Wu Lin, Hsin-Ting Tsai, Yu-Sheng Lin, Chang-Chun Hsiao*, Chang-Han Chen*
    • Development and Validation of a Novel Serum Predictive Marker for Patients with Metastatic Colorectal Cancer on Regorafenib Treatment. Cancers 2021, 13, 5080. (SCI;IF=5.2; Oncology 71/242)

      Yu-Li Su *, Kai-Lung Tsai, Tai-Jan Chiu, Yueh-Ming Lin, Ko-Chao Lee, Chien-Chang Lu, Hong-Hwa Chen, Chia-Che Wu, Hung-Chih Hsu*
    • Ribophorin II Overexpression Is Associated with Poor Response to Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil in P16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma. J Clin Med. 2021 Sep 12;10(18):4118 (SCI;IF=3.9; Medicine, General&internal 58/170)

      Chen WS, Luo SD, Chiu TJ, Wang YM, Chen WC, Chien CY, Fang FM, Huang TL, Li SH.
    • Sex Differences in Otolaryngology: Focus on the Emerging Role of Estrogens in Inflammatory and Pro-Resolvin Responses. Int J Mol Sci. 2021 Aug 16;22(16):8768. doi: 10.3390/ijms22168768. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)

      Luo SD, Chiu TJ, Chen WC, Wang CS.
    • Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma. Sci Rep. 2021 Aug 25;11(1):17161. doi: 10.1038/s41598-021-96614-y (SCI;IF=4.6; Multidisciplinary sciences 21/73)

      Luo SD, Wu SC, Chen WC, Wu CN, Chiu TJ, Yang YH, Li SH, Fang FM, Huang TL, Hsiao CC, Chen CH.
    • Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Front Oncol. 2020 Nov 27;10:584834. doi: 10.3389/fonc.2020.584834. eCollection 2020(SCI;IF=4.7; Oncology 85/242)

      Kuo MC, Su PJ, Huang CC, Luo HL, Chiu TJ, Li SH, Wu CC, Liu TT, Cheng YT, Kang CH, Su YL.
    • Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma PLoS One. 2020 Dec 11;15(12):e0240791. doi: 10.1371/journal.pone.0240791. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)

      Tai-Jan Chiu*, Yi-Ju Chen, Fang?Ying Kuo, Yen-Yang Chen.
    • The Clinical Impacts of Pretreatment Peripheral Blood Ratio on Lymphocytes, Monocytes, and Neutrophils Among Patients with Laryngeal/Hypopharyngeal Cancer Treated by Chemoradiation/Radiation. Cancer Manag Res. 2020 Sep 25;12:9013-9021. doi: 10.2147/CMAR.S275635. (SCI;IF=3.3; Oncology 135/242)

      Chuang HC, Tsai MH, Lin YT, Chou MH, Huang TL, Chiu TJ, Lu H, Fang FM, Chien CY.
    • Predictors of hospital expenses and hospital stay among patients undergoing total laryngectomy: Cost effectiveness analysis. PLoS One. 2020 Jul 16;15(7):e0236122. doi: 10.1371/journal.pone.0236122. eCollection 2020. (SCI;IF=3.7; MULTIDISCIPLINARY SCIENCES 26/73)

      Tsai MH, Chuang HC, Lin YT, Lu H, Fang FM, Huang TL, Chiu TJ, Li SH, Chien CY.
    • Inactivation of APC Induces CD34 Upregulation to Promote Epithelial- Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer. Int J Mol Sci. 2020 Jun 23;21(12): E4473. doi: 10.3390/ijms21124473. (SCI;IF=5.6; Biochemistry & molecular biology 65/285)

      Chiu TJ*, Hsieh MJ, Lin YC, Weng CC, Weng YT, Hsiao CC, Cheng KH.
    • Low-Dose Aspirin Use Significantly Improves the Survival of Late-stage NPC: A Propensity Score-Matched Cohort Study in Taiwan. Cancers (Basel). 2020 Jun 12;12(6):E1551. doi: 10.3390/cancers12061551. (SCI;IF=5.2; Oncology 71/242)

      Luo SD, Chen WC, Wu CN, Yang YH, Li SH, Fang FM, Huang TL, Wang YM, Chiu TJ*, Wu SC.
    • Pancreatic stellate cells activated by mutant KRAS- mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8. Theranostics. 2019 Sep 23;9(24):7168-7183. doi: 10.7150/thno.36830. eCollection 2019. (SCI;IF=12.4; MEDICINE, RESEARCH & EXPERIMENTAL 8/136)

      Wang HC, Lin YL, Hsu CC, Chao YJ, Hou YC, Chiu TJ, Huang PH, Tang MJ, Chen LT, Shan YS.
    • Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung Cancer. Cancer Cell. 2018 Dec 10;34(6):954-969.e4. doi: 10.1016/j.ccell.2018.11.007. (SCI;IF=50.3; Cell Biology 4/191)

      Lee PC, Fang YF, Yamaguchi H, Wang WJ, Chen TC, Hong X, Ke B, Xia W, Wei Y, Zha Z, Wang Y, Kuo HP, Wang CW, Tu CY, Chen CH, Huang WC, Chiang SF, Nie L, Hou J, Chen CT, Huo L, Yang WH, Deng R, Nakai K, Hsu YH, Chang SS, Chiu TJ, Tang J, Zhang R, Wang L, Fang B, Chen T, Wong KK, Hsu JL, Hung MC.
    • Osteopontin Expression Is Associated with the Poor Prognosis in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy. Biomed Res Int. 2018 Apr 30;2018:9098215. doi: 10.1155/2018/9098215. (SCI;IF=3.246; Biotechnology &applied microbiology 89/162)

      Chiu TJ*, Lu HI, Chen CH, Huang WT, Wang YM, Lin WC, Li SH.
    • Oncogenic Fibulin-5 SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; Surgery 146/213)

      Ma MC, Chiu TJ, Lu HI, Huang WT, Lo CM, Tien WY, Lan YC, Chen YY, Chen CH, Li SH.
    • SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma. J Cardiothorac Surg. 2018 Apr 10;13(1):25. (SCI;IF=1.6; CARDIAC & CARDIOVASCULAR SYSTEMS 119/143)

      Ma MC*, Chiu TJ, Lu HI, Huang WT, Lo CM, Tien WY, Lan YC, Chen YY, Chen CH, Li SH.
    • Combinatorial Methods of Immunotherapy Open New Opportunities in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Review article. International Journal of Head and Neck Science 2(1): 5-13, 2018. (non-SCI)

      Tai-Jan Chiu*.
    • Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma. BMC Cancer. 2018 Feb 27;18(1):227. (SCI;IF=3.8; Oncology 109/242)

      Ma MC*, Chen YJ*, Chiu TJ, Lan J, Liu CT, Chen YC, Tien HH, Chen YY.
    • High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy. Mol Med Rep. 2017 Nov;16(5):7185- 7190. doi: 10.3892/mmr.2017.7555. (SCI;IF=3.2; Surgery 47/213)

      Rau KM, Su YL, Li SH, Hsieh MC, Wu SC, Chou FF, Chiu TJ, Chen YH, Liu CT.
    • Treatment Outcome of Patients with Unresectable Stage IVB Head and Neck Squamous Cell Carcinoma Receiving Induction Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil. International Journal of Head and Neck Science 1(2): 121-130, 2017 (non-SCI)

      Tai-Jan Chiu*, Sheng-Dean Luo, Chih-Yen Chien, Yan-Ye